- Co-Diagnostics (NASDAQ:CODX) +176% on eliminating debt.
- Eyenovia (NASDAQ:EYEN) +52% on positive MicroStat data.
- Ekso Bionics Holdings (NASDAQ:EKSO) +33% on $100M JV to develop the Exoskeleton market in Asia.
- Foresight Autonomous Holdings (NASDAQ:FRSX) +17% on receiving $1M investment from RH Electronics at $4.08 per ADS.
- Can-Fite BioPharma (NYSEMKT:CANF) +15% on publication of data supporting piclidenoson and namodenson.
- BioTime (NYSEMKT:BTX) +12% as its affiliate OncoCyte has reported positive results from an R&D validation study of DetermaVu.
- Advanced Micro Devices (NASDAQ:AMD) +10% on Q4 results.
- Oshkosh (NYSE:OSK) +10% on Q1 results.
- Companhia Siderurgica Nacional (NYSE:SID) +9%.
- ICICI Bank (NYSE:IBN) +8%.
- Vale S.A. (NYSE:VALE) +8% as the company outlined plans to cut production.
- Mellanox Technologies (NASDAQ:MLNX) +8% on Intel (NASDAQ:INTC) offer.
- Staffing 360 Solutions (NASDAQ:STAF) +8% on initiating quarterly dividend.
- Anthem (NYSE:ANTM) +7% on Q4 results.
- Zynerba Pharmaceuticals (NASDAQ:ZYNE) +7%.
- Stryker (NYSE:SYK) +7% on Q4 results.
- Cleveland-Cliffs (NYSE:CLF) +7%.
- Boeing (NYSE:BA) +7% on Q4 results.
- TG Therapeutics (NASDAQ:TGTX) +5% on positive TG-1101/TGR-1202 data.
- Now read: Oshkosh Corporation 2019 Q1 - Results - Earnings Call Slides
Original article